JP7498499B2 - 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復 - Google Patents

心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復 Download PDF

Info

Publication number
JP7498499B2
JP7498499B2 JP2021510297A JP2021510297A JP7498499B2 JP 7498499 B2 JP7498499 B2 JP 7498499B2 JP 2021510297 A JP2021510297 A JP 2021510297A JP 2021510297 A JP2021510297 A JP 2021510297A JP 7498499 B2 JP7498499 B2 JP 7498499B2
Authority
JP
Japan
Prior art keywords
aav
cells
nuclease
composition
muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021510297A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019213626A5 (https=
JP2021522858A5 (https=
JP2021522858A (ja
Inventor
エイミー ジェイ． ウェイガーズ，
ケクシアン ジュ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard University
Original Assignee
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard University filed Critical Harvard University
Publication of JP2021522858A publication Critical patent/JP2021522858A/ja
Publication of JPWO2019213626A5 publication Critical patent/JPWO2019213626A5/ja
Publication of JP2021522858A5 publication Critical patent/JP2021522858A5/ja
Priority to JP2024085010A priority Critical patent/JP2024100980A/ja
Application granted granted Critical
Publication of JP7498499B2 publication Critical patent/JP7498499B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14142—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2021510297A 2018-05-03 2019-05-03 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復 Active JP7498499B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024085010A JP2024100980A (ja) 2018-05-03 2024-05-24 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862666685P 2018-05-03 2018-05-03
US62/666,685 2018-05-03
PCT/US2019/030748 WO2019213626A1 (en) 2018-05-03 2019-05-03 In vivo homology directed repair in heart, skeletal muscle, and muscle stem cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024085010A Division JP2024100980A (ja) 2018-05-03 2024-05-24 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復

Publications (4)

Publication Number Publication Date
JP2021522858A JP2021522858A (ja) 2021-09-02
JPWO2019213626A5 JPWO2019213626A5 (https=) 2022-05-10
JP2021522858A5 JP2021522858A5 (https=) 2022-05-10
JP7498499B2 true JP7498499B2 (ja) 2024-06-12

Family

ID=68386147

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021510297A Active JP7498499B2 (ja) 2018-05-03 2019-05-03 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復
JP2024085010A Pending JP2024100980A (ja) 2018-05-03 2024-05-24 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024085010A Pending JP2024100980A (ja) 2018-05-03 2024-05-24 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復

Country Status (7)

Country Link
US (1) US20210363546A1 (https=)
EP (1) EP3787692A4 (https=)
JP (2) JP7498499B2 (https=)
CN (1) CN112512595A (https=)
AU (1) AU2019262225B2 (https=)
CA (1) CA3099332A1 (https=)
WO (1) WO2019213626A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9828582B2 (en) 2013-03-19 2017-11-28 Duke University Compositions and methods for the induction and tuning of gene expression
US10676726B2 (en) 2015-02-09 2020-06-09 Duke University Compositions and methods for epigenome editing
EA201891317A3 (ru) 2015-11-30 2019-04-30 Дьюк Юниверсити Терапевтические мишени для коррекции гена дистрофина человека с помощью редактирования генов и способы их применения
US20190127713A1 (en) 2016-04-13 2019-05-02 Duke University Crispr/cas9-based repressors for silencing gene targets in vivo and methods of use
WO2018017754A1 (en) 2016-07-19 2018-01-25 Duke University Therapeutic applications of cpf1-based genome editing
WO2019144061A1 (en) 2018-01-19 2019-07-25 Duke University Genome engineering with crispr-cas systems in eukaryotes
US12486519B2 (en) 2018-08-18 2025-12-02 President And Fellows Of Harvard College In situ gene editing
EP4125349A4 (en) * 2020-04-27 2024-07-10 Duke University GENE EDITING OF SATELLITE CELLS IN VIVO USING AAV VECTORS ENCODING MUSCLE-SPECIFIC PROMOTERS
CN115181722B (zh) * 2022-08-30 2024-06-11 江苏农牧科技职业学院 一种鹅骨骼肌卫星细胞的体外分离和培养方法
WO2024229028A2 (en) * 2023-05-01 2024-11-07 University Of Washington Novel regulatory cassettes for specific expression of genes in muscle stem cells
WO2025260086A1 (en) * 2024-06-14 2025-12-18 President And Fellows Of Harvard College In vivo site-specific base editing

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017525696A (ja) 2014-08-11 2017-09-07 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム Ｃｒｉｓｐｒ／ｃａｓ９媒介遺伝子編集による筋ジストロフィーの予防
WO2018013932A1 (en) 2016-07-15 2018-01-18 Salk Institute For Biological Studies Methods and compositions for genome editing in non-dividing cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2931897T3 (en) * 2012-12-12 2018-02-05 Broad Inst Inc CONSTRUCTION, MODIFICATION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTICAL APPLICATIONS
US20170362635A1 (en) * 2016-06-20 2017-12-21 University Of Washington Muscle-specific crispr/cas9 editing of genes
EP3516058A1 (en) * 2016-09-23 2019-07-31 Casebia Therapeutics Limited Liability Partnership Compositions and methods for gene editing

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017525696A (ja) 2014-08-11 2017-09-07 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム Ｃｒｉｓｐｒ／ｃａｓ９媒介遺伝子編集による筋ジストロフィーの予防
WO2018013932A1 (en) 2016-07-15 2018-01-18 Salk Institute For Biological Studies Methods and compositions for genome editing in non-dividing cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Scientific Report，2017年，7:9363

Also Published As

Publication number Publication date
EP3787692A1 (en) 2021-03-10
US20210363546A1 (en) 2021-11-25
CA3099332A1 (en) 2019-11-07
JP2021522858A (ja) 2021-09-02
WO2019213626A1 (en) 2019-11-07
JP2024100980A (ja) 2024-07-26
AU2019262225A1 (en) 2021-01-07
AU2019262225B2 (en) 2025-08-21
EP3787692A4 (en) 2022-03-23
CN112512595A (zh) 2021-03-16

Similar Documents

Publication Publication Date Title
JP7498499B2 (ja) 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復
CN114174520B (zh) 用于选择性基因调节的组合物和方法
JP2022093425A (ja) 高効率ゲノム編集のためのアデノ随伴ウイルスベクターバリアント及びその方法
JP7085716B2 (ja) Ｒｎａガイド遺伝子編集及び遺伝子調節
JP2021511803A (ja) ヒト心筋細胞におけるジストロフィン変異を修正するための組成物および方法
JP2023549456A (ja) デュシェンヌ型筋ジストロフィーの処置のための大きい変異ホットスポットの二重ａａｖベクター媒介欠失
JP2023515710A (ja) ＣＲＩＳＰＲ媒介式エクソン欠失用の最適なｇＲＮＡ対を発見するためのハイスループットスクリーニング法
AU2019358519A1 (en) Selection by means of artificial transactivators
WO2021108363A1 (en) Crispr/cas-mediated upregulation of humanized ttr allele
US20230272428A1 (en) Methods and compositions for correction of dmd mutations
US20250304955A1 (en) Compositions and methods for myosin heavy chain base editing
WO2023024504A1 (en) Crispr-cas13 system for treating sod1-associated diseases
CN117980482A (zh) Rbm20突变的基因组编辑
CN117561331A (zh) 用于产生经基因修饰的原代细胞的方法和组合物
US12486519B2 (en) In situ gene editing
WO2023206088A1 (en) Rna base editor for treating dmd-associated diseases
Zhu In Vivo Gene Editing of Muscles and Muscle Stem Cells Using AAV-CRISPR
Wong Utilization of CRISPR/Cas9-mediated gene editing for correction of deletion mutations in DMD
KR20240027748A (ko) Rbm20 돌연변이의 게놈 편집
WO2026005012A1 (ja) インビトロ及びインビボのゲノム編集における相同組換えの効率を高める方法
WO2025067403A1 (zh) 用于治疗血红蛋白疾病的组合物和方法
KR20250141243A (ko) 데그론 융합 단백질 및 그의 생산 및 사용 방법
CN117980484A (zh) 新颖的转录因子
JP2024517939A (ja) 編集タンパク質の発現のための方法および組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220426

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220426

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230512

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230809

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231012

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240301

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240424

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240524

R150 Certificate of patent or registration of utility model

Ref document number: 7498499

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150